about
From Linkage Studies to Epigenetics: What We Know and What We Need to Know in the Neurobiology of SchizophreniaIs Schizotypy per se a Suitable Endophenotype of Schizophrenia? - Do Not Forget to Distinguish Positive from Negative FacetsA pilot multivariate parallel ICA study to investigate differential linkage between neural networks and genetic profiles in schizophrenia.A Role for Oxytocin in the Etiology and Treatment of Schizophrenia.Research in people with psychosis risk syndrome: a review of the current evidence and future directionsConsensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics.Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia.Animal models to improve our understanding and treatment of suicidal behaviorLocal gyrification index in probands with psychotic disorders and their first-degree relativesPharmacology of epigenetics in brain disordersNeurocognitive Impairments in Unaffected First-degree Relatives of Schizophrenia.Aberrant Processing of Deviant Stimuli in Schizophrenia Revealed by Fusion of FMRI and EEG Data.ATA homozigosity in the IL-10 gene promoter is a risk factor for schizophrenia in Spanish females: a case control study.Revealing a brain network endophenotype in families with idiopathic generalised epilepsy.Genetic associations of brain structural networks in schizophrenia: a preliminary studyMotor deficits in schizophrenia quantified by nonlinear analysis of postural sway.Pathways from cannabis to psychosis: a review of the evidence.Smooth pursuit and visual occlusion: active inference and oculomotor control in schizophrenia.Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit.DISC1 is associated with cortical thickness and neural efficiencyComponents of cross-frequency modulation in health and disease.Impaired top-down modulation of saccadic latencies in patients with schizophrenia but not in first-degree relativesImpact of neurocognition on social and role functioning in individuals at clinical high risk for psychosis.Schizophrenia: a systemic disorderAssociation between Dopamine Receptor D2 (DRD2) Variations rs6277 and rs1800497 and Cognitive Performance According to Risk Type for Psychosis: A Nested Case Control Study in a Finnish Population Sample.Beyond the broken error-related negativity: functional and diagnostic correlates of error processing in psychosis.White matter alterations in first episode treatment-naïve patients with deficit schizophrenia: a combined VBM and DTI study.A dimensional approach to the psychosis spectrum between bipolar disorder and schizophrenia: the Schizo-Bipolar Scale.Increased Cerebellar Functional Connectivity With the Default-Mode Network in Unaffected Siblings of Schizophrenia Patients at RestUsing human brain imaging studies as a guide toward animal models of schizophrenia.Does the cognitive architecture of simplex and multiplex ASD families differ?Poor school performance in offspring of patients with schizophrenia: what are the mechanisms?Gray matter volume alterations in first-episode drug-naïve patients with deficit and nondeficit schizophrenia.Neurophysiological evidence of impaired self-monitoring in schizotypal personality disorder and its reversal by dopaminergic antagonism.COMT, neuropsychological function and brain structure in schizophrenia: a systematic review and neurobiological interpretation.Convergent approaches for defining functional imaging endophenotypes in schizophreniaThe Major Histocompatibility Complex (MHC) in Schizophrenia: A Review.Differences in resting-state functional magnetic resonance imaging functional network connectivity between schizophrenia and psychotic bipolar probands and their unaffected first-degree relatives.Developments in schizophrenia genetics: from linkage to microchips, deletions and duplications.Evaluation of state and trait biomarkers in healthy volunteers for the development of novel drug treatments in schizophrenia.
P2860
Q26744755-174D3873-71B3-454B-BEB1-7C28554F43EDQ26777959-59DE7DED-BB3F-4544-B9D1-3C1D48FAFC95Q28266007-425EA100-97F3-46B3-B384-E3F82ACB11B0Q30408983-CA7976CB-F657-46D3-8C65-D5C9637740E7Q30475598-9A9214AC-8B90-4C53-A0F3-4DC2F62CD21CQ31108616-CB70346D-4902-487E-9DDD-85D65B072F61Q33627250-44568B80-E1AE-41A4-B1F9-99BF9B326DFFQ33635653-664B596D-E843-4D48-8FBE-9768FF81C76CQ33655392-EE8B583D-5E48-4908-A135-B801206237D7Q33673025-0ADB09E7-8816-4633-9EF9-F90E9A20C5E3Q33771987-6F4F7B9A-0A09-4396-93C9-2EEC677B562FQ33823642-9FAEBFC8-7151-4633-952C-E3D6DCB180A5Q33928098-F57514D1-2099-4510-B7AD-70FBFDF10403Q34323609-43742329-C774-4FE2-9AB9-07B97EAAADC0Q34343604-C56402BB-9CD1-4A64-9078-695289C36453Q34369065-22B6CFA9-D15D-4B65-8020-DE5551261996Q34378233-E2CA22E2-F2BE-4583-8223-53E6A4FBC664Q34460451-17B70E27-8DF6-4716-96FE-A01013EC5904Q34619903-7DA1EC73-76BC-4609-86B6-79E08B963126Q35112848-BE539FFF-9074-452E-8D46-4FB8F4F234CBQ35113940-2256EFED-4080-4AE0-9717-7CD9420E68DCQ35115397-B5FA067E-0023-46CD-944E-205125069918Q35234966-DF8574F9-D415-48D5-900F-28EB6B9BD681Q35323907-74592BBB-A1FF-45DD-B51B-E3ED5FB16729Q35675412-C9775A8A-B121-462A-919E-9638711DBD8EQ35907178-502B2615-CC01-45B1-81FA-08F5CA9FD3C1Q35932602-202ABAB3-97A3-45BD-8266-F9BCC11BDFC6Q36054826-19393501-CA67-41A6-B6AA-AC5D1668D2B9Q36148511-A41D496D-BA1E-4A54-A796-7B100FF97116Q36332602-85CE9FA1-5F9F-4427-BD89-20F785A98150Q36494427-34424580-23B7-4843-ABE1-C31F5ACEA81DQ36856060-069325D9-3C65-4F0E-B221-25505515DC2BQ36877510-2EC3045C-FEEF-4AC2-891A-96D5DF3DE58FQ37009643-553FB7EC-D10B-4262-88F7-359AC47E38B8Q37284307-C333113E-1B7C-40C5-914C-D9641A589408Q37450579-41AEE91F-1123-4C89-A160-E1F2C04AFA68Q37626366-F08EB798-7DEC-4102-A8D4-80CCB487E2E5Q37670592-07D610CA-B20B-4F93-B0B4-824CC3755061Q37832739-02B5464E-3199-4222-AEF8-17DEA0F48F4BQ37945156-C086B6B9-8112-411C-81C8-9F272020822C
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Endophenotypes in schizophrenia: a selective review.
@ast
Endophenotypes in schizophrenia: a selective review.
@en
type
label
Endophenotypes in schizophrenia: a selective review.
@ast
Endophenotypes in schizophrenia: a selective review.
@en
prefLabel
Endophenotypes in schizophrenia: a selective review.
@ast
Endophenotypes in schizophrenia: a selective review.
@en
P2093
P2860
P1476
Endophenotypes in schizophrenia: a selective review.
@en
P2093
Allyssa J Allen
Bradley S Folley
Godfrey D Pearlson
Keith A Hawkins
Mélina E Griss
P2860
P356
10.1016/J.SCHRES.2009.01.016
P407
P577
2009-02-15T00:00:00Z